Drugs / supplemental autologous serum
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01514344 | Dec 2011 → Oct 2014 | ocular adnexal lymphoma | Andres J. M. Ferreri | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | supplemental autologous serum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01514344 ↗ |